ESTIMATED
(AS OF MARCH 31)
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 12/31/2022 | Q2 2023 | -$0.00 | $812,117 | 08/31/2022 | Q1 2023 | -$0.00 | $762,980 | 08/31/2022 | Q4 2022 | -$0.00 | $954,269 | 03/31/2022 | Q3 2022 | -$0.00 | $1.03 M | 12/31/2021 | Q2 2022 | -$0.00 | $857,079 | 09/03/2021 | Q1 2022 | -$0.00 | $852,434 | 09/02/2021 | Q4 2021 | -$0.00 | $920,918 | 03/31/2021 | Q3 2021 | -$0.00 | $932,880 | 12/31/2020 | Q2 2021 | -$0.00 | $726,030 | 08/31/2020 | Q1 2021 | -$0.00 | $674,157 | 09/15/2020 | Q4 2020 | -$0.00 | $-640,155 | 03/31/2020 | Q3 2020 | -$0.00 | $-570,436 | 02/27/2020 | Q2 2020 | -$0.00 | $650,846 | 09/30/2019 | Q1 2020 | -$0.00 | $626,070 | 08/30/2019 | Q4 2019 | -$0.00 | $886,214 | 03/31/2019 | Q3 2019 | -$0.00 | $896,283 | 02/28/2019 | Q2 2019 | -$0.00 | $854,588 | 09/30/2018 | Q1 2019 | -$0.00 | $876,885 | 08/31/2018 | Q4 2018 | -$0.00 | $610,010 | 03/31/2018 | Q3 2018 | -$0.00 | $633,160 |
---|
A. Alterity Therapeutics Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 30th, 2024 based off last year's report dates.
A. The conference call for Alterity Therapeutics Limited's latest earnings report can be listened to online.
A. The conference call transcript for Alterity Therapeutics Limited's latest earnings report can be read online.
A. Alterity Therapeutics Limited (NASDAQ:ATHE) has a recorded annual revenue of $2.61 M.
A. Alterity Therapeutics Limited (NASDAQ:ATHE) has a recorded net income of $2.61 M. Alterity Therapeutics Limited has generated $-0.0057 earnings per share over the last four quarters.